Local Doctor weighs in on Merck & Moderna personalized mRNA cancer treatment

{
  "signal_id": "675abd7e-b0da-25ff-2da8-b1fa9c9e83e5",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-08-22T19:52:06+00:00",
  "company": {
    "name": "Merck",
    "domain": "merck.com"
  },
  "data": {
    "url": "https://www.rochesterfirst.com/news/health/local-doctor-weighs-in-on-merck-moderna-personalized-mrna-cancer-treatment/amp/",
    "title": "Local Doctor weighs in on Merck & Moderna personalized mRNA cancer treatment - RochesterFirst",
    "excerpt": "ROCHESTER, N.Y. (WROC)- Health officials say a potential new weapon in the fight against melanoma is showing promising results. Moderna and Merck say their new personalized mRNA treatment helped prevent the deadly skin cancer from spreading or returning in late-stage clinical trials. While the treatment has not yet received FDA approval, local experts say the results could represent a major step forward in personalized cancer care. “It’s a true novel. Targeted personalized medicine, which is something very exciting,” said Dr. Gian Vinelli, head of dermatology at Rochester Regional Health. According to researchers, melanoma is one of the most common and deadliest forms of cancer in the United States. The disease often develops due to genetic factors or prolonged exposure to ultraviolet rays from the sun. Melanoma can appear as unusual spots or growths on the skin and may be difficult to diagnose in its early stages. “It can start to grow in irregular shapes on the body and eventually can bleed or ulcerate, kind of opening up,” Vinelli said. When detected early, melanoma is typically treated with surgery. However, patients diagnosed in later stages may require radiation therapy, chemotherapy, or other advanced treatments. The cancer is usually treated with surgery if you catch it in the early stages. But if it goes unnoticed until the later stages, patients may have to endure...",
    "product": "personalized mRNA cancer treatment",
    "summary": "Merck and Moderna are co-developing a personalized mRNA cancer treatment that has shown promising results in late-stage clinical trials for preventing melanoma from spreading or returning.",
    "planning": true,
    "image_url": "https://www.rochesterfirst.com/wp-content/uploads/sites/66/2026/08/SKIN-CANCER.jpeg?w=1280",
    "confidence": 0.9,
    "product_data": {
      "name": "personalized mRNA treatment",
      "full_text": "personalized mRNA treatment",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "future_tech"
    ],
    "published_at": "2026-08-22T19:52:06Z",
    "article_sentence": "Moderna and Merck say their new personalized mRNA treatment helped prevent the deadly skin cancer from spreading or returning in late-stage clinical trials.",
    "related_company_name": "Moderna",
    "related_company_domain": "modernatx.com"
  }
}

curl https://signals.autobound.ai/v1/signals/675abd7e-b0da-25ff-2da8-b1fa9c9e83e5 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"merck.com","limit":20}'